Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Ondansetron (10mg) Injection
Therapeutic Category
Gastroenterology
Dosage Form
Injection
Packaging Type
Ampule
Packaging
5x2ml
Price
₹0/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Ondotyle 10 Injection contains Ondansetron 10mg, a selective serotonin (5-HT3) receptor antagonist used for effective control of nausea and vomiting. It works by blocking serotonin receptors involved in triggering the vomiting reflex, ensuring reliable symptom control.
This injection is widely administered in chemotherapy-induced nausea, radiotherapy-associated vomiting, and postoperative nausea, making it an essential supportive therapy in hospital and clinical settings.
For franchise partners, Ondotyle 10 Injection represents a high-rotation product in the antiemetic segment, driven by consistent hospital demand and routine use across oncology and surgical care. Its strong prescriber acceptance supports steady secondary sales.
With increasing emphasis on supportive care medicines, Ondotyle 10 Injection offers stable business growth opportunities, helping partners strengthen their injectable portfolio in the antiemetic therapy segment.
Ondotyle 10 Injection is indicated for the prevention and treatment of nausea and vomiting associated with chemotherapy, radiotherapy, and postoperative conditions. It is also useful in managing severe vomiting of various causes when oral therapy is not feasible.
Ondotyle 10 Injection should be administered under medical supervision. Caution is advised in patients with cardiac disorders, electrolyte imbalance, or liver impairment. It should be used carefully in patients receiving other medicines that may prolong the QT interval.
Store Ondotyle 10 Injection in a cool, dry place below 25°C, protected from light. Do not freeze. Keep out of reach of children and do not use after the expiry date printed on the ampoule.
Composition : Granisetron (1mg) Injection
Composition : Ondansetron (2mg) + Ranitidine (25mg)
Composition : Ondansetron (2mg)
Composition : Ondansetron (8 mg) MD
Composition : Ondansetron (4mg) MD
Composition : Ondansetron (4mg) + Rabeprazole (20mg)
Composition : Desloratadine (5mg) + Montelukast (10mg)
Composition : Levocetirizine (2.5mg) + Montelukast (4mg) Bilayered
Composition : Levocetirizine (5mg) + Montelukast (10mg) Bilayered
Composition : Ebastine (10mg) Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Ondansetron 10mg Injection has strong demand in the hospital care, critical care, oncology, surgery, and gastroenterology segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on injectable and supportive care portfolios.
Medical distributors and agencies can benefit from consistent demand for nausea and vomiting management under medical supervision. Ondansetron 10mg is a selective 5-HT3 receptor antagonist that helps prevent and control nausea and vomiting Commonly prescribed for post-operative nausea and vomiting, chemotherapy-induced nausea and vomiting, radiotherapy-induced nausea, and severe gastroenteritis-associated vomiting as advised by healthcare professionals Injectable formulation provides rapid onset of action, making it suitable for emergency and hospital settings Frequently used in hospitals, emergency departments, oncology units, surgical wards, and critical care units Widely prescribed by oncologists, anesthesiologists, gastroenterologists, physicians, and surgeons This strengthens a comprehensive supportive care and hospital care portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Ondansetron 10mg Injection with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong hospital demand, institutional procurement opportunities, repeat orders, reliable supply chain support, and attractive margins in the injectable supportive care segment.
Interested distributors, stockists, and wholesalers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality pharmaceutical products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.